Integration of transcriptomics, proteomics, and metabolomics data to reveal HER2-associated metabolic heterogeneity in gastric cancer with response to immunotherapy and neoadjuvant chemotherapy

BACKGROUND: Currently available prognostic tools and focused therapeutic methods result in unsatisfactory treatment of gastric cancer (GC). A deeper understanding of human epidermal growth factor receptor 2 (HER2)-coexpressed metabolic pathways may offer novel insights into tumour-intrinsic precisio...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Qihang, Deng, Dawei, Pan, Chen, Ren, Jie, Wei, Tianfu, Wu, Zeming, Zhang, Biao, Li, Shuang, Yin, Peiyuan, Shang, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389544/
https://www.ncbi.nlm.nih.gov/pubmed/35990657
http://dx.doi.org/10.3389/fimmu.2022.951137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389544/
https://www.ncbi.nlm.nih.gov/pubmed/35990657
http://dx.doi.org/10.3389/fimmu.2022.951137

Ejemplares similares